personalized medicine Metastatic Tumor Subtypes Found With Expression Profiling Researchers unearthed four metastatic tumor molecular subtypes based on gene expression profiles in patient-derived xenograft and human tumor samples. Guardant Health, Royal Marsden Partner on Prospective Liquid Biopsy Trial in Early Colorectal Cancer The study is evaluating the Guardant Reveal assay to guide chemotherapy treatment decisions following surgery for stage II to III colorectal cancer. Personalis to Lay off up to 30 Percent of Workforce The company estimated that the reduction will save it approximately $17 million in operating costs for the remainder of this year. Estonian Team Building Personalized Medicine Center of Excellence With €30M in National, EU Funding Premium Among many objectives, the project will perform whole-genome sequencing of 10,000 individuals to build out its reference genome set. Caris Life Sciences Taps Juniper Biologics to Market Sequencing Tests in Southeast Asia The move will make Caris' comprehensive cancer sequencing services available to physicians and patients in the region. Jan 10, 2023 Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test Jan 5, 2023 Pharmacotyping Links Childhood Leukemia Subtypes to Treatment Response Dec 22, 2022 Genomic Medicine Adoption May be Hindered by Shortcomings in ICD-10 Coding Premium Dec 16, 2022 EU Awards €4.8M to Support Transition of NGS Workflows to Clinical Settings Premium Dec 12, 2022 T-Cell Subpopulations in Blood May Help Predict Immune Checkpoint Immunotherapy Side Effects Dec 9, 2022 Exact Sciences Takes Aim at Radiotherapy Response Prediction With New Gene Expression Data Premium Dec 6, 2022 Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Nov 28, 2022 OncoDNA, Eli Lilly Partner on Thyroid Cancer Biomarker Testing Nov 22, 2022 South Carolina Population Genomics Program Marks First Anniversary With Surge in Participation Premium Nov 18, 2022 NeoGenomics, ImmunoGen Ink Testing Deal for Newly Approved Folate Receptor Drug Nov 17, 2022 Asa Ren, G42 Healthcare Partner to Promote Genomics, Bioinformatics in Indonesia Nov 10, 2022 Cancer Patients in Early Trial Receive Personalized, CRISPR-Edited T-Cell Therapy Nov 8, 2022 SimBioSys Gets $2M NCI Award for Tumor Visualization, Analysis Platform Nov 7, 2022 Pathologists Evaluate Implementation of PGDx Comprehensive Genomic Profiling Kit Premium Oct 24, 2022 Molecular Tumor Board Therapy Matching Predicts Immunotherapy Best Responders Premium Sep 27, 2022 GATC Health, Akon Lighting to Generate AI-Driven Genomic Insights From Over 1M Africans Sep 22, 2022 Cowen Initiates Coverage of 23andMe With Outperform Rating Sep 21, 2022 Liquid Biopsy Firm Hedera Dx Raises €14M in Seed Funding Sep 7, 2022 Matched Therapy 'Evidence Scale' Predicts Targeted Treatment Efficacy in Breast Cancer Patients Sep 7, 2022 Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain Premium Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.